{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:43:43Z","timestamp":1785473023063,"version":"3.56.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Polish National Science Centre","doi-asserted-by":"crossref","award":["UMO-2019\/34\/E\/NZ1\/00467"],"award-info":[{"award-number":["UMO-2019\/34\/E\/NZ1\/00467"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NAWA Polish Returns","award":["PPN\/PPO\/2018\/1\/00046\/U\/00001"],"award-info":[{"award-number":["PPN\/PPO\/2018\/1\/00046\/U\/00001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The selective inhibition of kinases from the diabetic kinome is known to promote the regeneration of beta cells and provide an opportunity for the curative treatment of diabetes. The effect can be achieved by carefully tailoring the selectivity of inhibitor toward a particular kinase, especially DYRK1A, previously associated with Down syndrome and Alzheimer's disease. Recently DYRK1A inhibition has been shown to promote both insulin secretion and beta cells proliferation. Here, we show that commonly available flavones are effective inhibitors of DYRK1A. The observed biochemical activity of flavone compounds is confirmed by crystal structures solved at 2.06\u00a0\u00c5 and 2.32\u00a0\u00c5 resolution, deciphering the way inhibitors bind in the ATP-binding pocket of the kinase, which is driven by the arrangement of hydroxyl moieties. We also demonstrate antidiabetic properties of these biomolecules and prove that they could be further improved by therapy combined with TGF-\u03b2 inhibitors. Our data will allow future structure-based optimization of the presented scaffolds toward potent, bioavailable and selective anti-diabetic drugs.<\/jats:p>","DOI":"10.1038\/s41598-023-44810-3","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T14:03:04Z","timestamp":1698069784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics"],"prefix":"10.1038","volume":"13","author":[{"given":"Katarzyna","family":"Pustelny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Grygier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Barzowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pucelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Mrowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Slugocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz M.","family":"Popowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Czarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"44810_CR1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0091270010376972","volume":"51","author":"S Akkati","year":"2011","unstructured":"Akkati, S., Sam, K. G. & Tungha, G. Emergence of promising therapies in diabetes mellitus. J. Clin. Pharmacol. 51, 796\u2013804 (2011).","journal-title":"J. Clin. Pharmacol."},{"key":"44810_CR2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","volume":"8","author":"L Chen","year":"2012","unstructured":"Chen, L., Magliano, D. J. & Zimmet, P. Z. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat. Rev. Endocrinol. 8, 228\u2013236 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"44810_CR3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/nu9121310","volume":"9","author":"A Alkhatib","year":"2017","unstructured":"Alkhatib, A. et al. Functional foods and lifestyle approaches for diabetes prevention and management. Nutrients 9, 1310 (2017).","journal-title":"Nutrients"},{"key":"44810_CR4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/nu10060698","volume":"10","author":"J Mijatovic-Vukas","year":"2018","unstructured":"Mijatovic-Vukas, J. et al. Associations of diet and physical activity with risk for gestational diabetes mellitus: A systematic review and meta-analysis. Nutrients 10, 698 (2018).","journal-title":"Nutrients"},{"key":"44810_CR5","first-page":"222","volume":"3","author":"ML Falcone Ferreyra","year":"2012","unstructured":"Falcone Ferreyra, M. L., Rius, S. P. & Casati, P. Flavonoids: Biosynthesis, biological functions, and biotechnological applications. Front. Plant Sci. 3, 222 (2012).","journal-title":"Front. Plant Sci."},{"key":"44810_CR6","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche, A. N., Diwan, A. D. & Chandra, S. R. Flavonoids: An overview. J. Nutr. Sci. 5, e47 (2016).","journal-title":"J. Nutr. Sci."},{"key":"44810_CR7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/biom9090430","volume":"9","author":"RK Al-Ishaq","year":"2019","unstructured":"Al-Ishaq, R. K., Abotaleb, M., Kubatka, P., Kajo, K. & B\u00fcsselberg, D. Flavonoids and their anti-diabetic effects: Cellular mechanisms and effects to improve blood sugar levels. Biomolecules 9, 430 (2019).","journal-title":"Biomolecules"},{"key":"44810_CR8","first-page":"100059","volume":"5","author":"EG Halevas","year":"2022","unstructured":"Halevas, E. G., Avgoulas, D. I., Katsipis, G. & Pantazaki, A. A. Flavonoid-liposomes formulations: Physico-chemical characteristics, biological activities and therapeutic applications. Eur. J. Med. Chem. Rep. 5, 100059 (2022).","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"44810_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/plants5020027","volume":"5","author":"N Jiang","year":"2016","unstructured":"Jiang, N., Doseff, A. I. & Grotewold, E. Flavones: From biosynthesis to health benefits. Plants 5, 27 (2016).","journal-title":"Plants"},{"key":"44810_CR10","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.3390\/molecules27238133","volume":"27","author":"DK Isika","year":"2022","unstructured":"Isika, D. K. & Sadik, O. A. Selective structural derivatization of flavonoid acetamides significantly impacts their bioavailability and antioxidant properties. Molecules 27, 8133 (2022).","journal-title":"Molecules"},{"key":"44810_CR11","doi-asserted-by":"crossref","first-page":"e0260853","DOI":"10.1371\/journal.pone.0260853","volume":"16","author":"M Bitew","year":"2021","unstructured":"Bitew, M. et al. Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study. PLoS One 16, e0260853 (2021).","journal-title":"PLoS One"},{"key":"44810_CR12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0197-4580(02)00075-1","volume":"23","author":"H Schroeter","year":"2002","unstructured":"Schroeter, H. et al. MAPK signaling in neurodegeneration: Influences of flavonoids and of nitric oxide. Neurobiol. Aging 23, 861\u2013880 (2002).","journal-title":"Neurobiol. Aging"},{"key":"44810_CR13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.freeradbiomed.2004.01.001","volume":"36","author":"RJ Williams","year":"2004","unstructured":"Williams, R. J., Spencer, J. P. E. & Rice-Evans, C. Flavonoids: Antioxidants or signalling molecules?. Free Radic. Biol. Med. 36, 838\u2013849 (2004).","journal-title":"Free Radic. Biol. Med."},{"key":"44810_CR14","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.3390\/molecules16065159","volume":"16","author":"D Kong","year":"2011","unstructured":"Kong, D., Zhang, Y., Yamori, T., Duan, H. & Jin, M. Inhibitory activity of flavonoids against class I phosphatidylinositol 3-kinase isoforms. Molecules 16, 5159 (2011).","journal-title":"Molecules"},{"key":"44810_CR15","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.3390\/ijms222212455","volume":"22","author":"TA Zughaibi","year":"2021","unstructured":"Zughaibi, T. A., Suhail, M., Tarique, M. & Tabrez, S. Targeting PI3K\/Akt\/mTOR pathway by different flavonoids: A cancer chemopreventive approach. Int. J. Mol. Sci. 22, 12455 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"44810_CR16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-3623(98)00220-1","volume":"32","author":"L Gamet-Payrastre","year":"1999","unstructured":"Gamet-Payrastre, L. et al. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen. Pharmacol. 32, 279\u2013286 (1999).","journal-title":"Gen. Pharmacol."},{"key":"44810_CR17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1039\/C6FO01873D","volume":"8","author":"F Jiang","year":"2017","unstructured":"Jiang, F. et al. Flavonoids from sea buckthorn inhibit the lipopolysaccharide-induced inflammatory response in RAW264.7 macrophages through the MAPK and NF-\u03baB pathways. Food Funct. 8, 1313\u20131322 (2017).","journal-title":"Food Funct."},{"key":"44810_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10111546","volume":"10","author":"A Baier","year":"2020","unstructured":"Baier, A. & Szyszka, R. Compounds from natural sources as protein kinase inhibitors. Biomolecules 10, 1\u201330 (2020).","journal-title":"Biomolecules"},{"key":"44810_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jmb.2012.10.019","volume":"425","author":"S Baek","year":"2013","unstructured":"Baek, S. et al. Structural and functional analysis of the natural JNK1 inhibitor quercetagetin. J. Mol. Biol. 425, 411 (2013).","journal-title":"J. Mol. Biol."},{"key":"44810_CR20","doi-asserted-by":"crossref","first-page":"902092","DOI":"10.3389\/fnagi.2022.902092","volume":"14","author":"C Wei","year":"2022","unstructured":"Wei, C. et al. Network pharmacology identify intersection genes of quercetin and Alzheimer\u2019s disease as potential therapeutic targets. Front. Aging Neurosci. 14, 902092 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"44810_CR21","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.3390\/ijms22169083","volume":"22","author":"B Pucelik","year":"2021","unstructured":"Pucelik, B., Barzowska, A., D\u0105browski, J. M. & Czarna, A. Diabetic kinome inhibitors\u2014A new opportunity for \u03b2-cells restoration. Int. J. Mol. Sci. 22, 9083 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"44810_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11010-016-2878-8","volume":"426","author":"KC Nandipati","year":"2017","unstructured":"Nandipati, K. C., Subramanian, S. & Agrawal, D. K. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance. Mol. Cell Biochem. 426, 27\u201345 (2017).","journal-title":"Mol. Cell Biochem."},{"key":"44810_CR23","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.2174\/138161212800672688","volume":"18","author":"H Zhou","year":"2012","unstructured":"Zhou, H. & Li, Y. Rho kinase inhibitors: Potential treatments for diabetes and diabetic complications. Curr. Pharm. Des. 18, 2964\u20132973 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"44810_CR24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/BST0330339","volume":"33","author":"MP Coghlan","year":"2005","unstructured":"Coghlan, M. P. & Smith, D. M. Introduction to the kinases in diabetes biochemical society focused meeting: Are protein kinases good targets for antidiabetic drugs?. Biochem. Soc. Trans. 33, 339\u2013342 (2005).","journal-title":"Biochem. Soc. Trans."},{"key":"44810_CR25","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/ja309304m","volume":"135","author":"W Shen","year":"2013","unstructured":"Shen, W. et al. Small-molecule inducer of \u03b2 cell proliferation identified by high-throughput screening. J. Am. Chem. Soc. 135, 1669\u20131672 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"44810_CR26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00125-018-4639-6","volume":"61","author":"E Karakose","year":"2018","unstructured":"Karakose, E., Ackeifi, C., Wang, P. & Stewart, A. F. Advances in drug discovery for human beta cell regeneration. Diabetologia 61, 1693 (2018).","journal-title":"Diabetologia"},{"key":"44810_CR27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","volume":"21","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat. Med. 21, 383\u2013388 (2015).","journal-title":"Nat. Med."},{"key":"44810_CR28","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/acs.jmedchem.0c02050","volume":"64","author":"K Kumar","year":"2021","unstructured":"Kumar, K. et al. DYRK1A inhibitors as potential therapeutics for \u03b2-cell regeneration for diabetes. J. Med. Chem. 64, 2901\u20132922 (2021).","journal-title":"J. Med. Chem."},{"key":"44810_CR29","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1210\/en.2009-1294","volume":"151","author":"Z Fu","year":"2010","unstructured":"Fu, Z. et al. Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology 151, 3026\u20133037 (2010).","journal-title":"Endocrinology"},{"key":"44810_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/303902","author":"JM Li","year":"2013","unstructured":"Li, J. M. et al. Quercetin preserves \u03b2-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt\/FoxO1 activation. Evid. Based Complement. Alternat. Med. https:\/\/doi.org\/10.1155\/2013\/303902 (2013).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"44810_CR31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jnutbio.2018.02.017","volume":"57","author":"R Varshney","year":"2018","unstructured":"Varshney, R. et al. Kaempferol alleviates palmitic acid-induced lipid stores, endoplasmic reticulum stress and pancreatic \u03b2-cell dysfunction through AMPK\/mTOR-mediated lipophagy. J. Nutr. Biochem. 57, 212\u2013227 (2018).","journal-title":"J. Nutr. Biochem."},{"key":"44810_CR32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/en.2003-1099","volume":"145","author":"A Merglen","year":"2004","unstructured":"Merglen, A. et al. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145, 667\u2013678 (2004).","journal-title":"Endocrinology"},{"key":"44810_CR33","doi-asserted-by":"crossref","first-page":"W209","DOI":"10.1093\/nar\/gks396","volume":"40","author":"SR Bonden","year":"2012","unstructured":"Bonden, S. R. & Nausi, C. C. RF-Cloning.org: An online tool for the design of restriction-free cloning projects. Nucleic Acids Res. 40, W209\u2013W213 (2012).","journal-title":"Nucleic Acids Res."},{"key":"44810_CR34","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JMEDCHEM.2C01887","author":"P Grygier","year":"2023","unstructured":"Grygier, P. et al. Silmitasertib (CX-4945), a clinically used CK2-kinase inhibitor with additional effects on GSK3\u03b2 and DYRK1A kinases: A structural perspective. J. Med. Chem. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.2C01887 (2023).","journal-title":"J. Med. Chem."},{"key":"44810_CR35","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/bi00266a011","volume":"21","author":"PF Cook","year":"1982","unstructured":"Cook, P. F. et al. Adenosine cyclic 3\u2019,5\u2019-monophosphate dependent protein kinase: Kinetic mechanism for the bovine skeletal muscle catalytic subunit. Biochemistry 21, 5794\u20135799 (1982).","journal-title":"Biochemistry"},{"key":"44810_CR36","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1021\/acs.jmedchem.7b01847","volume":"61","author":"A Czarna","year":"2018","unstructured":"Czarna, A. et al. Novel scaffolds for dual specificity tyrosine-phosphorylation-regulated kinase (DYRK1A) inhibitors. J. Med. Chem. 61, 7560\u20137572 (2018).","journal-title":"J. Med. Chem."},{"key":"44810_CR37","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3390\/cells10092263","volume":"10","author":"A Barzowska","year":"2021","unstructured":"Barzowska, A. et al. DYRK1A kinase inhibitors promote \u03b2-cell survival and insulin homeostasis. Cells 10, 2263 (2021).","journal-title":"Cells"},{"key":"44810_CR38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"44810_CR39","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution?. Acta Crystallogr. D Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"44810_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"44810_CR41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: Recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"44810_CR42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"44810_CR43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"44810_CR44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"44810_CR45","unstructured":"Welcome to Global Phasing Limited. https:\/\/www.globalphasing.com\/."},{"key":"44810_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2005.00327.x","author":"W Sherman","year":"2006","unstructured":"Sherman, W., Beard, H. S. & Farid, R. Use of an induced fit receptor structure in virtual screening. Chem. Biol. Drug Des. https:\/\/doi.org\/10.1111\/j.1747-0285.2005.00327.x (2006).","journal-title":"Chem. Biol. Drug Des."},{"key":"44810_CR47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221\u2013234 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"44810_CR48","doi-asserted-by":"publisher","unstructured":"Bowers, K. J. et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. in Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, SC\u201906 (2006). doi:https:\/\/doi.org\/10.1145\/1188455.1188544.","DOI":"10.1145\/1188455.1188544"},{"key":"44810_CR49","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.3390\/ijms21228716","volume":"21","author":"A Su\u0142ek","year":"2020","unstructured":"Su\u0142ek, A., Pucelik, B., Kobielusz, M., Barzowska, A. & D\u0105browski, J. M. Photodynamic inactivation of bacteria with porphyrin derivatives: Effect of charge, lipophilicity, ros generation, and cellular uptake on their biological activity in vitro. Int. J. Mol. Sci. 21, 8716 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"44810_CR50","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0963689718798564","volume":"27","author":"S Pellegrini","year":"2018","unstructured":"Pellegrini, S. et al. Differentiation of sendai virus-reprogrammed iPSC into \u03b2 cells, compared with human pancreatic islets and immortalized \u03b2 cell line. Cell Transplant. 27, 1548 (2018).","journal-title":"Cell Transplant."},{"key":"44810_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/846742","author":"Y Fu","year":"2014","unstructured":"Fu, Y. et al. Baicalein protects against type 2 diabetes via promoting islet \u03b2-cell function in obese diabetic mice. Int. J. Endocrinol. https:\/\/doi.org\/10.1155\/2014\/846742 (2014).","journal-title":"Int. J. Endocrinol."},{"key":"44810_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2019.04.005","volume":"854","author":"Z Yang","year":"2019","unstructured":"Yang, Z., Huang, W., Zhang, J., Xie, M. & Wang, X. Baicalein improves glucose metabolism in insulin resistant HepG2 cells. Eur. J. Pharmacol. 854, 187\u2013193 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"44810_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/267890","author":"HY Li","year":"2012","unstructured":"Li, H. Y. et al. Comparative study of the effect of baicalin and its natural analogs on neurons with oxygen and glucose deprivation involving innate immune reaction of TLR2\/TNF\u03b1. J. Biomed. Biotechnol. https:\/\/doi.org\/10.1155\/2012\/267890 (2012).","journal-title":"J. Biomed. Biotechnol."},{"key":"44810_CR54","doi-asserted-by":"crossref","first-page":"109102","DOI":"10.1016\/j.biopha.2019.109102","volume":"117","author":"S Yang","year":"2019","unstructured":"Yang, S. et al. Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage. Biomed. Pharmacother. 117, 109102 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"44810_CR55","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/acs.jnatprod.0c00014","volume":"83","author":"C Proen\u00e7a","year":"2020","unstructured":"Proen\u00e7a, C. et al. Structural specificity of flavonoids in the inhibition of human fructose 1,6-bisphosphatase. J. Nat. Prod. 83, 1541\u20131552 (2020).","journal-title":"J. Nat. Prod."},{"key":"44810_CR56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.6026\/97320630015179","volume":"15","author":"P Singh","year":"2019","unstructured":"Singh, P., Singh, V. K. & Singh, A. K. Molecular docking analysis of candidate compoundsderived from medicinal plants with type 2 diabetes mellitus targets. Bioinformation 15, 179\u2013188 (2019).","journal-title":"Bioinformation"},{"key":"44810_CR57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijbiomac.2017.06.066","volume":"104","author":"F Li","year":"2017","unstructured":"Li, F. et al. Molecular interaction studies of acetylcholinesterase with potential acetylcholinesterase inhibitors from the root of Rhodiola crenulata using molecular docking and isothermal titration calorimetry methods. Int. J. Biol. Macromol. 104, 527\u2013532 (2017).","journal-title":"Int. J. Biol. Macromol."},{"key":"44810_CR58","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1476-5381.2010.00910.x","volume":"161","author":"E Youl","year":"2010","unstructured":"Youl, E. et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic \u03b2-cells against oxidative damage via the ERK1\/2 pathway. Br. J. Pharmacol. 161, 799\u2013814 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"44810_CR59","first-page":"64","volume":"4","author":"SO Adewole","year":"2006","unstructured":"Adewole, S. O., Caxton-Martins, E. A. & Ojewole, J. A. O. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr. J. Tradit. Complement. Altern. Med. 4, 64\u201374 (2006).","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"44810_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"G Zu","year":"2021","unstructured":"Zu, G. et al. Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus. Sci. Rep. 11, 1\u201311 (2021).","journal-title":"Sci. Rep."},{"key":"44810_CR61","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.3390\/molecules24122287","volume":"24","author":"PC Paula","year":"2019","unstructured":"Paula, P. C., Maria, S. G. A., Luis, C. H. & Patricia, C. G. G. Preventive effect of quercetin in a triple transgenic Alzheimer\u2019s disease mice model. Molecules 24, 2287 (2019).","journal-title":"Molecules"},{"key":"44810_CR62","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s42003-021-01685-2","volume":"4","author":"U Maitra","year":"2021","unstructured":"Maitra, U., Harding, T., Liang, Q. & Ciesla, L. GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson\u2019s disease. Commun. Biol. 4, 162 (2021).","journal-title":"Commun. Biol."},{"key":"44810_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/754931","author":"EA Mohamed","year":"2015","unstructured":"Mohamed, E. A., Ahmad, M., Ang, L. F., Asmawi, M. Z. & Yam, M. F. Evaluation of \u03b1-glucosidase inhibitory effect of 50% ethanolic standardized extract of Orthosiphon Stamineus benth in normal and streptozotocin-induced diabetic rats. Evid. Based Complement. Alternat. Med. https:\/\/doi.org\/10.1155\/2015\/754931 (2015).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"44810_CR64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1472-6882-12-176","volume":"12","author":"EAH Mohamed","year":"2012","unstructured":"Mohamed, E. A. H. et al. Potent \u03b1-glucosidase and \u03b1-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism. BMC Complement. Altern. Med. 12, 176 (2012).","journal-title":"BMC Complement. Altern. Med."},{"key":"44810_CR65","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s11626-020-00478-x","volume":"56","author":"R Zhang","year":"2020","unstructured":"Zhang, R. et al. Apigetrin ameliorates streptozotocin-induced pancreatic \u03b2-cell damages via attenuating endoplasmic reticulum stress. In Vitro Cell Dev. Biol. Anim. 56, 622\u2013634 (2020).","journal-title":"In Vitro Cell Dev. Biol. Anim."},{"key":"44810_CR66","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.jnutbio.2020.108427","volume":"83","author":"SM Kim","year":"2020","unstructured":"Kim, S. M. et al. Apigetrin induces extrinsic apoptosis, autophagy and G2\/M phase cell cycle arrest through PI3K\/AKT\/mTOR pathway in AGS human gastric cancer cell. J. Nutr. Biochem. 83, 108427 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"44810_CR67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1753-0407.2011.00145.x","volume":"4","author":"T Venkatesan","year":"2012","unstructured":"Venkatesan, T. & Sorimuthu Pillai, S. Antidiabetic activity of gossypin, a pentahydroxyflavone glucoside, in streptozotocin-induced experimental diabetes in rats. J. Diabetes 4, 41\u201346 (2012).","journal-title":"J. Diabetes"},{"key":"44810_CR68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4103\/0253-7613.121367","volume":"45","author":"VM Chandrashekhar","year":"2013","unstructured":"Chandrashekhar, V. M., Ganapaty, S., Ramkishan, A. & Narsu, M. L. Neuroprotective activity of gossypin from Hibiscus vitifolius against global cerebral ischemia model in rats. Indian J. Pharmacol. 45, 575\u2013580 (2013).","journal-title":"Indian J. Pharmacol."},{"key":"44810_CR69","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF02980089","volume":"27","author":"I Yoon","year":"2004","unstructured":"Yoon, I., Kwang, H. L. & Cho, J. Gossypin protects primary cultured rat cortical cells from oxidative stress- and beta-amyloid-induced toxicity. Arch. Pharm. Res. 27, 454\u2013459 (2004).","journal-title":"Arch. Pharm. Res."},{"key":"44810_CR70","first-page":"247","volume":"13","author":"M Omidi","year":"2020","unstructured":"Omidi, M., Ahangarpour, A., Khorsandi, L. & Ramezani-AliAkbari, F. The antidiabetic and hepatoprotective effects of myricitrin on aged mice with D-galactose. Gastroenterol. Hepatol. Bed Bench 13, 247 (2020).","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"44810_CR71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/np100572z","volume":"74","author":"JR Jones","year":"2011","unstructured":"Jones, J. R. et al. The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau. J. Nat. Prod. 74, 38\u201344 (2011).","journal-title":"J. Nat. Prod."},{"key":"44810_CR72","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/ijms21051870","volume":"21","author":"DY Kim","year":"2020","unstructured":"Kim, D. Y., Kim, S. R. & Jung, U. J. Myricitrin ameliorates hyperglycemia, glucose intolerance, hepatic steatosis, and inflammation in high-fat diet\/streptozotocin-induced diabetic mice. Int. J. Mol. Sci. 21, 1870 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"44810_CR73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11010-006-9244-1","volume":"293","author":"N Kamalakkannan","year":"2006","unstructured":"Kamalakkannan, N. & Prince, P. S. M. Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol. Cell. Biochem. 293, 211\u2013219 (2006).","journal-title":"Mol. Cell. Biochem."},{"key":"44810_CR74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jbt.20117","volume":"20","author":"PS Mainzen Prince","year":"2006","unstructured":"Mainzen Prince, P. S. & Kamalakkannan, N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol. 20, 96\u2013102 (2006).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"44810_CR75","doi-asserted-by":"crossref","first-page":"eaau6328","DOI":"10.1126\/sciadv.aau6328","volume":"5","author":"RY Pan","year":"2019","unstructured":"Pan, R. Y. et al. Sodium rutin ameliorates Alzheimer\u2019s disease-like pathology by enhancing microglial amyloid-\u03b2 clearance. Sci. Adv. 5, eaau6328 (2019).","journal-title":"Sci. Adv."},{"key":"44810_CR76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbr.2014.02.002","volume":"264","author":"P Xu","year":"2014","unstructured":"Xu, P. et al. Rutin improves spatial memory in Alzheimer\u2019s disease transgenic mice by reducing A\u03b2 oligomer level and attenuating oxidative stress and neuroinflammation. Behav. Brain Res. 264, 173\u2013180 (2014).","journal-title":"Behav. Brain Res."},{"key":"44810_CR77","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.3390\/ijms23169355","volume":"23","author":"E Deboever","year":"2022","unstructured":"Deboever, E., Fistrovich, A., Hulme, C. & Dunckley, T. The omnipresence of DYRK1A in human diseases. Int. J. Mol. Sci. 23, 9355 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"44810_CR78","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2174\/1570159X16666180803162059","volume":"17","author":"AC Silveira","year":"2019","unstructured":"Silveira, A. C. et al. The action of polyphenols in diabetes mellitus and Alzheimer\u2019s disease: A common agent for overlapping pathologies. Curr. Neuropharmacol. 17, 590\u2013613 (2019).","journal-title":"Curr. Neuropharmacol."},{"key":"44810_CR79","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1101\/gad.11.8.957","volume":"11","author":"JA Diehl","year":"1997","unstructured":"Diehl, J. A., Zindy, F. & Sherr, C. J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11, 957\u2013972 (1997).","journal-title":"Genes Dev."},{"key":"44810_CR80","doi-asserted-by":"crossref","first-page":"e0172985","DOI":"10.1371\/journal.pone.0172985","volume":"12","author":"H Liu","year":"2017","unstructured":"Liu, H. et al. NFATc1 phosphorylation by DYRK1A increases its protein stability. PLoS One 12, e0172985 (2017).","journal-title":"PLoS One"},{"key":"44810_CR81","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1021\/acs.jmedchem.2c02068","volume":"66","author":"MF Lindberg","year":"2023","unstructured":"Lindberg, M. F. et al. Comparative efficacy and selectivity of pharmacological inhibitors of DYRK and CLK protein kinases. J. Med. Chem. 66, 4106\u20134130 (2023).","journal-title":"J. Med. Chem."},{"key":"44810_CR82","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.1021\/jm401049v","volume":"56","author":"S Gourdain","year":"2013","unstructured":"Gourdain, S. et al. Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity. J. Med. Chem. 56, 9569\u20139585 (2013).","journal-title":"J. Med. Chem."},{"key":"44810_CR83","doi-asserted-by":"publisher","unstructured":"Grygier, P., Pustelny, K., Dubin, G. & Czarna, A. Structural perspective on the design of selective DYRK1B inhibitors. bioRxiv 2022.12.23.521429 (2022) doi:https:\/\/doi.org\/10.1101\/2022.12.23.521429.","DOI":"10.1101\/2022.12.23.521429"},{"key":"44810_CR84","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/cmdc.202000183","volume":"15","author":"YA Liu","year":"2020","unstructured":"Liu, Y. A. et al. A dual inhibitor of DYRK1A and GSK3\u03b2 for \u03b2-cell proliferation: Aminopyrazine derivative GNF4877. ChemMedChem 15, 1562\u20131570 (2020).","journal-title":"ChemMedChem"},{"key":"44810_CR85","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.cmet.2018.12.005","volume":"29","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. Combined inhibition of DYRK1A, SMAD, and trithorax pathways synergizes to induce robust replication in adult human beta cells. Cell Metab. 29, 638-652.e5 (2019).","journal-title":"Cell Metab."},{"key":"44810_CR86","doi-asserted-by":"crossref","first-page":"eaaw9996","DOI":"10.1126\/scitranslmed.aaw9996","volume":"12","author":"C Ackeifi","year":"2020","unstructured":"Ackeifi, C. et al. GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human \u03b2 cell regeneration. Sci. Transl. Med. 12, eaaw9996 (2020).","journal-title":"Sci. Transl. Med."},{"key":"44810_CR87","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","volume":"127","author":"X Sun","year":"2018","unstructured":"Sun, X. & Kaufman, P. D. Ki-67: More than a proliferation marker. Chromosoma 127, 175\u2013186 (2018).","journal-title":"Chromosoma"},{"key":"44810_CR88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 1, 337\u2013341 (2004).","journal-title":"Drug Discov. Today Technol."},{"key":"44810_CR89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/2231-4040.104709","volume":"3","author":"C Veeresham","year":"2012","unstructured":"Veeresham, C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Technol. Res. 3, 200 (2012).","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"44810_CR90","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1182\/blood-2007-01-067256","volume":"109","author":"AB Kunnumakkara","year":"2007","unstructured":"Kunnumakkara, A. B. et al. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-\u03baB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis. Blood 109, 5112\u20135121 (2007).","journal-title":"Blood"},{"key":"44810_CR91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biochi.2018.05.012","volume":"151","author":"KE Hamilton","year":"2018","unstructured":"Hamilton, K. E. et al. Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1. Biochimie 151, 107\u2013114 (2018).","journal-title":"Biochimie"},{"key":"44810_CR92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","volume":"20","author":"MA Ansari","year":"2009","unstructured":"Ansari, M. A., Abdul, H. M., Joshi, G., Opii, W. O. & Butterfield, D. A. Protective effect of quercetin in primary neurons against A\u03b2(1\u201342): Relevance to Alzheimer\u2019s disease. J. Nutr. Biochem. 20, 269\u2013275 (2009).","journal-title":"J. Nutr. Biochem."},{"key":"44810_CR93","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","volume":"93","author":"AM Sabogal-Gu\u00e1queta","year":"2015","unstructured":"Sabogal-Gu\u00e1queta, A. M. et al. The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice. Neuropharmacology 93, 134\u2013145 (2015).","journal-title":"Neuropharmacology"},{"key":"44810_CR94","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.lfs.2011.09.023","volume":"89","author":"K Jim\u00e9nez-Aliaga","year":"2011","unstructured":"Jim\u00e9nez-Aliaga, K., Bermejo-Besc\u00f3s, P., Bened\u00ed, J. & Mart\u00edn-Arag\u00f3n, S. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci. 89, 939\u2013945 (2011).","journal-title":"Life Sci."},{"key":"44810_CR95","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.bcp.2013.08.066","volume":"86","author":"S Choi","year":"2013","unstructured":"Choi, S. et al. Rutin inhibits B[a]PDE-induced cyclooxygenase-2 expression by targeting EGFR kinase activity. Biochem. Pharmacol. 86, 1468\u20131475 (2013).","journal-title":"Biochem. Pharmacol."},{"key":"44810_CR96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.abb.2014.05.016","volume":"559","author":"KS Choi","year":"2014","unstructured":"Choi, K. S., Kundu, J. K., Chun, K. S., Na, H. K. & Surh, Y. J. Rutin inhibits UVB radiation-induced expression of COX-2 and iNOS in hairless mouse skin: P38 MAP kinase and JNK as potential targets. Arch. Biochem. Biophys. 559, 38\u201345 (2014).","journal-title":"Arch. Biochem. Biophys."},{"key":"44810_CR97","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1074\/jbc.275.4.2431","volume":"275","author":"S Himpel","year":"2000","unstructured":"Himpel, S. et al. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J. Biol. Chem. 275, 2431\u20132438 (2000).","journal-title":"J. Biol. Chem."},{"key":"44810_CR98","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/10715769900301141","volume":"31","author":"PCH Hollman","year":"2009","unstructured":"Hollman, P. C. H. et al. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic. Res. 31, 569\u2013573. https:\/\/doi.org\/10.1080\/10715769900301141 (2009).","journal-title":"Free Rad. Res."},{"key":"44810_CR99","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/ph16030443","volume":"16","author":"GL Araldi","year":"2023","unstructured":"Araldi, G. L. & Hwang, Y. W. Development of novel fluorinated polyphenols as selective inhibitors of DYRK1A\/B kinase for treatment of neuroinflammatory diseases including Parkinson\u2019s disease. Pharmaceuticals 16, 443 (2023).","journal-title":"Pharmaceuticals"},{"key":"44810_CR100","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/s41598-018-20984-z","volume":"8","author":"F Neumann","year":"2018","unstructured":"Neumann, F. et al. DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives. Sci. Rep. 8, 2859 (2018).","journal-title":"Sci. Rep."},{"key":"44810_CR101","doi-asserted-by":"publisher","DOI":"10.1039\/B905068J","author":"C S\u00e1nchez","year":"2009","unstructured":"S\u00e1nchez, C. et al. Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles. Chem. Commun. (Camb.) https:\/\/doi.org\/10.1039\/B905068J (2009).","journal-title":"Chem. Commun. (Camb.)"},{"key":"44810_CR102","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1021\/acs.jmedchem.8b00658","volume":"61","author":"K Kumar","year":"2018","unstructured":"Kumar, K. et al. Development of kinase-selective, harmine-based DYRK1A inhibitors that induce pancreatic human \u03b2-cell proliferation. J. Med. Chem. 61, 7687\u20137699 (2018).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44810-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44810-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44810-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T22:12:48Z","timestamp":1700604768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-44810-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["44810"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-44810-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18114"}}